Next Article in Journal
NRF2 in Viral Infection
Next Article in Special Issue
A Reductive Metabolic Switch Protects Infants with Transposition of Great Arteries Undergoing Atrial Septostomy against Oxidative Stress
Previous Article in Journal
H2O2-Mediated Oxidative Stress Enhances Cystathionine γ-Lyase-Derived H2S Synthesis via a Sulfenic Acid Intermediate
Previous Article in Special Issue
NAC and Vitamin D Improve CNS and Plasma Oxidative Stress in Neonatal HIE and Are Associated with Favorable Long-Term Outcomes
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 10
Issue 9
10.3390/antiox10091490
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Male Disadvantage in Oxidative Stress-Associated Complications of Prematurity: A Systematic Review, Meta-Analysis and Meta-Regression

by
Elke van Westering-Kroon
1,
Maurice J Huizing
1,
Eduardo Villamor-Martínez
1,2 and
Eduardo Villamor
1,*
1
Department of Pediatrics, Maastricht University Medical Center (MUMC+), School for Oncology and Developmental Biology (GROW), 6229HA Maastricht, The Netherlands
2
Statistics Netherlands, 6412HX Heerlen, The Netherlands
*
Author to whom correspondence should be addressed.
Antioxidants 2021, 10(9), 1490; https://doi.org/10.3390/antiox10091490
Submission received: 30 August 2021 / Accepted: 14 September 2021 / Published: 18 September 2021
(This article belongs to the Special Issue Metabolomics, Oxidative, and Nitrosative Stress in the Perinatal Period)
Browse Figures
Review Reports Versions Notes

Abstract

:
A widely accepted concept is that boys are more susceptible than girls to oxidative stress-related complications of prematurity, including bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP), necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH), and periventricular leukomalacia (PVL). We aimed to quantify the effect size of this male disadvantage by performing a systematic review and meta-analysis of cohort studies exploring the association between sex and complications of prematurity. Risk ratios (RRs) and 95% CIs were calculated by a random-effects model. Of 1365 potentially relevant studies, 41 met the inclusion criteria (625,680 infants). Male sex was associated with decreased risk of hypertensive disorders of pregnancy, fetal distress, and C-section, but increased risk of low Apgar score, intubation at birth, respiratory distress, surfactant use, pneumothorax, postnatal steroids, late onset sepsis, any NEC, NEC > stage 1 (RR 1.12, CI 1.06–1.18), any IVH, severe IVH (RR 1.28, CI 1.22–1.34), severe IVH or PVL, any BPD, moderate/severe BPD (RR 1.23, CI 1.18–1.27), severe ROP (RR 1.14, CI 1.07–1.22), and mortality (RR 1.23, CI 1.16–1.30). In conclusion, preterm boys have higher clinical instability and greater need for invasive interventions than preterm girls. This leads to a male disadvantage in mortality and short-term complications of prematurity.

1. Introduction

Preterm birth is defined as birth before 37 completed weeks of gestational age (GA) and is further subdivided in extremely (GA < 28 weeks), very (GA 28 to <32 weeks), moderate (GA 32 to <34 weeks), and late (GA 34 to <37 weeks) preterm birth. Prematurity, particularly in the in the lowest ranges of GA, is a leading cause of infant mortality, as well as long-term morbidity [1].
Two widely accepted concepts in neonatal medicine are the so-called “male disadvantage” and “oxygen radical disease in neonatology”. The first concept is supported by a large body of evidence showing that boys are more susceptible than girls to adverse outcomes of prematurity, including bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP), necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH), periventricular leukomalacia (PVL), chronic neurodevelopmental and cognitive impairment, and death [2,3,4,5,6,7].
The term “oxygen radical disease in neonatology” was coined by Saugstad in the 1980s when he hypothesized that complications of prematurity, such as BPD, ROP, NEC, IVH, or PVL, are different facets of one disease sharing a basic pathogenetic mechanism: increased oxidative stress and reduced endogenous antioxidant defenses [8,9]. Interestingly, preterm girls have higher antioxidant enzyme activity than preterm boys and it has been suggested that these differences may play a key role in the male disadvantage of prematurity [10,11,12].
Although the notion of male disadvantage of prematurity is more than five decades old, only sex-associated differences in mortality have been systematically reviewed [13]. Our current aim is to conduct a systematic review and meta-analysis on male-female differences in risk of developing oxidative stress-associated complications of prematurity. In addition to outcomes such as BPD, ROP, NEC, IVH, or PVL, we also analyzed potential male–female differences in obstetrical characteristics and clinical conditions in the first weeks of postnatal life. Finally, since it has been suggested that the male disadvantage of prematurity has undergone changes in the last few years [14], we investigated by meta-regression the influence of time and other variables on the association between infant sex and complications of prematurity.

2. Materials and Methods

The study was performed and reported according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) and meta-analysis of observational studies in epidemiology (MOOSE) guidelines [15]. Review protocol was registered in the PROSPERO international register of systematic reviews (ID = CRD42018095509). The research question was “Do preterm boys have a higher risk of developing short-term complications of prematurity than preterm girls?”

2.1. Sources and Search Strategy

A comprehensive literature search was undertaken using the PubMed and EMBASE databases. The search strategy is detailed in Table S1. No language limit was applied. The literature search was updated up to February 2021. Narrative reviews, systematic reviews, case reports, letters, editorials, and commentaries were excluded, but read to identify potential additional studies. Additional strategies to identify studies included manual review of reference lists from key articles that fulfilled our eligibility criteria, use of “related articles” feature in PubMed, and use of the “cited by” tool in Web of Science and Google scholar.

2.2. Study Selection

Studies were included if they had a prospective or retrospective cohort design, examined preterm (GA < 37 weeks) infants, and reported primary data that could be used to measure the association between infant sex and short-term complications of prematurity. We only selected studies in which infant sex was the independent variable and the perinatal characteristics and outcomes were the dependent variables. Studies that exclusively included late preterm infants (GA ≥ 34 weeks), or combined preterm and term infants were excluded. To identify relevant studies, two reviewers (E.V., E.V.-M.) independently screened the results of the searches and applied inclusion criteria using a structured form. Discrepancies were resolved through discussion or consultation with a third reviewer (M.J.H.).

2.3. Data Extraction and Quality Assessment

Two reviewers (E.V., E.V.-M.) extracted data from relevant studies using a predetermined data extraction form, and two reviewers (E.W.-K., M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. Data extracted from each study included citation information, language of publication, study design, location and frame time, patient characteristics, and results (including raw numbers or summary statistics when raw numbers were not available). Data were extracted for all obstetric and perinatal variables as well as clinical conditions and outcomes reported in each study.
Methodological quality was assessed using the Newcastle-Ottawa Scale (NOS) for cohort studies [15]. This scale assigns a maximum of 9 points (4 for selection, 2 for comparability, and 3 for outcome). NOS scores ≥ 7 were considered high-quality studies (low risk of bias), and scores of 5 to 6 denoted moderate quality (moderate risk of bias) [15].

2.4. Statistical Analysis

Meta-analysis was performed when at least three studies were identified that reported on the same variable or outcome measure. Studies were combined and analyzed using comprehensive meta-analysis V3.0 software (Biostat Inc., Englewood, NJ, USA). Due to anticipated heterogeneity, summary statistics were calculated with a random-effects model. This model accounts for variability between studies as well as within studies. For dichotomous outcomes, the risk ratio (RR) with 95% confidence interval (CI) was calculated. For continuous outcomes (example: GA), the mean difference (MD) with 95% CI was calculated. Statistical heterogeneity was assessed by Cochran’s Q statistic and by the I2 statistic. Potential sources of heterogeneity were assessed through subgroup analysis and/or random effects (method of moments) univariate meta-regression analysis as previously described [16,17]. For both categorical and continuous covariates, the R2 analog, defined as the total between-study variance explained by the moderator, was calculated based on the meta-regression matrix. Predefined sources of heterogeneity included the following characteristics of cohorts: mean or median GA, median year of birth, and geographical location (continent). We used the Egger’s regression test and funnel plots to assess publication bias. Subgroup analyses, meta-regression, and publication bias assessment were performed only for the main outcomes (BPD, IVH, PVL, ROP, NEC, and mortality) and when there were at least ten studies in the meta-analysis. A probability value of less than 0.05 (0.10 for heterogeneity) was considered statistically significant.

3. Results

3.1. Description of Studies and Quality Assessment

The flow diagram of the search process is shown in Figure S1. Of 1365 potentially relevant studies, 41 (including 625,680 infants, 319,470 males) were included [2,3,4,5,14,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53]. Their characteristics are summarized in Table S2. The percentage of males in the cohorts ranged from 41.2% [32] to 66.2% [20] with a pooled percentage of 52.2% (95% CI 51.4 to 53.0). Four studies included exclusively twin infants [24,35,44,51] and two studies included exclusively singleton infants [43,49]. The quality score of each study according to the Newcastle-Ottawa Scale is depicted in Table S2. All studies received at least seven points, indicating a low risk of bias.

3.1.1. Meta-Analysis

The following variables were reported in more than two studies and were therefore included in the meta-analysis: chorioamnionitis, hypertensive disorders of pregnancy, maternal diabetes, prenatal care, premature rupture of membranes, prolonged rupture of membranes, antepartum hemorrhage, antenatal corticosteroids, fetal distress, cesarean-section, birth in a non-tertiary hospital (outborn), 5′ Apgar score < 3, 5′ Apgar score < 7, intubation at birth, resuscitation at birth, birth weight (BW) below the 10th percentile, BW below the 3rd percentile or -2SD, early onset (<72 h) sepsis, late onset (>72 h) sepsis, undefined onset sepsis, hypotension, patent ductus arteriosus (PDA), respiratory distress syndrome (RDS), administration of surfactant, mechanical ventilation, pneumothorax, postnatal steroids, any BPD (defined as oxygen requirement on postnatal day 28), moderate/severe BPD (defined as oxygen requirement at the postmenstrual age of 36 weeks), any IVH (grade 1–4), severe IVH (grade 3–4), PVL, severe IVH or PVL, any ROP, severe ROP (stage ≥ 3 or requiring treatment), any NEC, NEC ≥ Stage II, and mortality before discharge.
The meta-analyses on obstetric and perinatal characteristics are summarized in Figure 1 and Table 1. The meta-analyses on clinical characteristics and outcomes are summarized in Figure 2 and Table 2. The individual meta-analyses for each outcome (BPD, IVH, PVL, ROP, NEC, and mortality) are shown in Figures S2–S12. Male sex was associated with a decreased risk of hypertensive disorders of pregnancy, fetal distress, and cesarean-section, but an increased risk of birth in a non-tertiary hospital, 5′ Apgar score < 3, intubation at birth, respiratory distress syndrome, surfactant use, pneumothorax, postnatal steroids, late onset sepsis, any BPD (Figure 2 and Figure S2), moderate/severe BPD (Figure 2 and Figure S3), any IVH (Figure 2 and Figure S4), severe IVH (Figure 2 and Figure S5), severe IVH or PVL (Figure 2 and Figure S7), severe ROP (Figure 2 and Figure S9), any NEC (Figure 2 and Figure S10), NEC ≥ stage II (Figure 2 and Figure S11), and mortality (Figure 2 and Figure S12). With regard to the continuous variables, BW was significantly higher in boys than in girls (Table 1). In contrast, no differences were found by infant sex in either GA or maternal age (Table 1).
Neither visual inspection of funnel plots (Figure S13) nor Egger’s test suggested publication or selection bias for any of the eligible meta-analyses (i.e., with at least ten studies).

3.1.2. Subgroup Analysis and Meta-Regression

Subgroup analysis based on the geographic location (continent) of the studies showed no significant differences for any of the outcomes analyzed, with only the exception of PVL (Table S2). The effect size of the association between male sex and PVL was significantly lower (meta-regression p = 0.048, R2-analog = 0.5) in the cohorts from America when compared with Asian and European cohorts (Table S3).
Meta-regression showed that the effect size of the association between male sex and mortality significantly decreased as the median year of the cohort increased (Figure 3A). In contrast, the association between male sex and the other outcomes did not correlate with the median year of birth of the cohort (Table S4). Meta-regression also showed that the effect size of the association between male sex and mortality significantly increased as the mean/median gestational age of the cohort increased (Figure 3B). The association between sex and the other outcomes did not correlate with the mean/median gestational age of the cohort (Table S4).

4. Discussion

To the best of our knowledge, this is the first systematic review and meta-analysis focused on male–female differences in short-term outcomes of prematurity. Our results confirm the presence of male disadvantage in mortality as well as relevant morbidities, including IVH, BPD, ROP, and NEC. Although the observed increases in risk are modest, they hold important implications for understanding preterm birth complications. Besides the short-term complications, we investigated whether other prognostic factors such as GA, birth weight, obstetric history, or clinical condition in the first days of life were different between boys and girls. We found no male–female differences in GA but the well-known difference is birth weight. In addition, meta-analysis showed that male sex was associated with decreased risk of being exposed to hypertension during pregnancy, developing fetal distress, and being born by cesarean section but increased risk of birth in a non-tertiary hospital, low Apgar score, intubation at birth, developing respiratory distress, being treated with surfactant and mechanical ventilation, developing pneumothorax, receiving postnatal steroids, and developing late onset sepsis. These differences in clinical course may have a major influence on the development of the pulmonary, neurological, ocular, and gastrointestinal complications of prematurity. On the other hand, our meta-analysis could not demonstrate that the rates of hypotension, PDA, or early onset sepsis were significantly different between boys and girls.
Male–female differences in human health and disease have been recognized for many years [54,55,56,57]. In reproductive and perinatal medicine, there are numerous studies dealing with sex differences, extending from fertilization and embryo implantation to the neonatal period [58,59,60,61,62,63,64,65,66]. The male to female ratio at birth is generally estimated to be around 1.05–1.06 [63,64,65,67]. This excess of males at birth is known for centuries and has been extensively studied by demographers, statisticians, epidemiologists, and biologists [63]. Focusing exclusively on preterm birth, the excess of males is even higher with male to female ratios around 1.2 [63,64,65,68,69]. However, the underlying mechanisms for this difference remain unclear, with suggestions including sexual dimorphism in embryonic and fetal homeostasis, as well as in the pathophysiological pathways that trigger preterm birth.
Preterm birth is always the result of a pathologic process, which may not only contribute to early delivery but may also adversely affect neonatal outcomes [16,70,71,72,73]. The pathophysiological pathways, or endotypes, leading to very and extreme preterm birth are divided into two main groups: (1) intrauterine infection/inflammation, and (2) dysfunctional placentation [16,70,71,72,73]. The first group is related to chorioamnionitis and placental microbial invasion and is associated with preterm labor, pre-labor premature rupture of membranes, placental abruption, and cervical insufficiency. The second group is associated with hypertensive disorders of pregnancy (including preeclampsia, eclampsia, and pregnancy-induced hypertension), and the entity identified as fetal indication/IUGR [16,70,71,72,73]. The association between fetal sex and prematurity endotype has been particularly examined in the case of the dysfunctional placentation endotype. A number of meta-analysis showed that preterm preeclampsia is associated with carrying a female fetus, while pregnancies with a male fetus are associated with developing term and post-term preeclampsia [61,62]. Accordingly, we observed an increased risk of hypertensive disorders of pregnancy and fetal distress associated with female sex. In contrast, there was no evidence of sexual dimorphism for conditions related to the infectious-inflammatory endotype, such as chorioamnionitis or rupture of membranes. Nevertheless, it should be taken into account that the low number of studies reporting on these prenatal conditions limits the power of the meta-analysis to detect possible differences. In fact, it has been suggested that pregnancy with a male fetus may favor a more pro-inflammatory intra-uterine environment, leading to a higher incidence of infection/inflammation-driven preterm birth [59,69,74]. Our group is currently conducting a meta-analysis exclusively focused on the association between fetal sex and endotype of prematurity.
Regardless of the imbalanced sex ratio at birth, the underlying mechanisms specifically responsible for the observed increase in neonatal morbidity in preterm boys are likely multifactorial and not yet fully elucidated. Possible explanations include male–female differences in mother–fetus interaction, rate of fetal development, molecular differences between sex chromosomes, epimutations that preferentially affect one sex, variations in antioxidant capacity, and hormonal differences [7,11,58,59,60,64,65,66]. Since the dawn of neonatology, the degree of pulmonary maturity at birth has been recognized as the critical factor in determining the survival and prognosis of preterm infants [75]. It was also noted early on that preterm boys had a higher rate and severity of respiratory distress syndrome than preterm girls [76]. This has been linked to the influence of sex hormones on lung development and maturation and to anatomic differences in lung development during fetal life [57,77,78]. As reviewed by Seaborn et al., the lung of male fetuses is exposed to higher levels of testosterone in the period preceding the surge of surfactant production [77,78]. Thereafter, both sexes are exposed to increasing levels of estradiol but the fetal lung has the capability to synthesize and inactivate sex hormones, and hence to modulate their action in a sex-dependent way [78]. The present meta-analysis confirms that the respiratory clinical course is less favorable in preterm boys than in preterm girls. As mentioned above, these differences in the first days of life may be critical for the later development of other complications of prematurity.
As mentioned in the introduction, oxidative stress plays a central pathogenic role in the development of most of the complications of prematurity [9,79,80]. Thus, sex differences in the development of antioxidant defenses are frequently pointed out as the key factor for male disadvantage among preterm infants [10,11,12]. From this perspective, the glutathione pathway is the most extensively studied [10,11,12]. Glutathione is the major endogenous soluble antioxidant in mammalian cells and its metabolism controls the intracellular levels of peroxides (via glutathione peroxidase), aldehydes (via glutathione S-transferase), and even radicals (via regeneration of oxidized vitamins C and E) [12]. As reviewed by Lavoie and Tremblay, numerous factors related to glutathione metabolism, including glutathione levels, activity of enzymes (glutathione peroxidase, glutathione reductase, glutathione S-transferase), and cellular uptake of cysteine have been found as sex-dependent in the placenta, umbilical cord, and blood cells of preterm infants [12]. Therefore, it has been suggested that antioxidant strategies in preterm infants should mainly target glutathione metabolism and be personalized considering, among others, the sex specificity [12].
The study cohorts included in our meta-analysis spanned a 30-year period (1986–2016) and some of the factors affecting outcome in the early 1990s may not be so relevant to current preterm populations. Moreover, it has been suggested that the advances in perinatal medicine, which have led to a decline in mortality and improved short-term outcomes for the most vulnerable preterm infants, have had a greater impact on boys than on girls [14]. Therefore, the male disadvantage of prematurity might be decreasing over the years [14]. We have tested this hypothesis by meta-regression and found that the male disadvantage in mortality among preterm infants tends to decrease as the cohorts include infants born in recent years. However, the increased risk of developing BPD, ROP, or NEC in males did not show this decreasing trend over the years. We also used meta-regression to analyze whether male disadvantage correlated with the gestational age of the cohort. Again, this meta-regression was only significant for mortality (Figure 3B). The association between male sex and risk of mortality decreased as the cohort had a lower mean gestational age. This effect of gestational age was not observed for any of the other complications of prematurity.
The major strength of our meta-analysis is the comprehensive database search to identify all the potential studies. Thus, the 41 included studies encompassed a total population of 625,680 infants from 16 different countries, providing a significant international representation. When we performed subgroup analyses based on continent, the only outcome where we found a significant geographic difference in sex ratio was PVL. It should be noted that, in contrast to the other outcomes analyzed, PVL was the only main complication of prematurity for which the meta-analysis did not show an increased risk associated with male sex. Subgroup analysis showed that the absence of male disadvantage for PVL was due to the marked differences between the American and the Asian and European cohorts (Table S2). Nevertheless, this finding may be an artifact due to the limited number of studies and therefore needs to be investigated in meta-analyses specifically focused on PVL. For all other outcomes, including IVH, BPD, ROP, NEC, and mortality, sub-group analysis did not show geographic differences, suggesting that the male disadvantage of prematurity is a ubiquitous phenomenon.
The main limitation of our systematic review is that studies were included only if sex was the independent variable and the association between sex and outcome was reported for more than one complication of prematurity. Although this design allowed for comparing the impact of male disadvantage on the different outcomes, we excluded a large number of studies in which an individual outcome was the independent variable and sex, among other potential risk factors, was the dependent variable. Our group is now analyzing these studies separately. The results of these meta-analyses, which for outcomes such as ROP or BPD include more than 250 studies, will confirm the present findings and analyze more comprehensively the influence of factors such as changes in trends over the years or geographic location on male disadvantage.

5. Conclusions

The present data suggest that the clinical course of preterm males is more complicated than that of females from the earliest moments of life. This higher clinical instability in males seems particularly to affect the respiratory system and leads to higher mortality and short-term morbidity. Complications such as BPD, ROP, NEC, IVH, or PVL will have a serious impact on post-discharge growth and neurodevelopment, extending the male disadvantage to the years of childhood and adolescence. In numerous studies on health conditions and neurocognitive outcomes of former preterm infants, adult females frequently perform better than adult males [1,7,81,82,83]. An improved understanding of sex-specific requirements of preterm infants may lead to optimized strategies to avoid the sequelae of early life oxidative stress and inflammation [7].

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/antiox10091490/s1, Table S1: Search strategy; Table S2: Characteristics of the included studies; Table S3: Subgroup analyses based on continent; Table S4: Meta-regression analysis (continuous covariates); Figure S1: Flow diagram of the systematic search; Figure S2: Meta-analysis of the association between male sex of preterm infants and risk of bronchopulmonary dysplasia (BPD), defined as oxygen requirement on postnatal day 28; Figure S3: Meta-analysis of the association between male sex of preterm infants and risk of bronchopulmonary dysplasia (BPD), defined as oxygen requirement at the postmenstrual age of 36 weeks; Figure S4: Meta-analysis of the association between male sex and risk of intraventricular hemorrhage (IVH, grade 1–4) in preterm infants; Figure S5: Meta-analysis of the association between male sex and risk of severe intraventricular hemorrhage (IVH grade 3–4) in preterm infants; Figure S6: Meta-analysis of the association between male sex and risk of periventricular leukomalacia (PVL) in preterm infants; Figure S7: Meta-analysis of the association between male sex of preterm infants and risk of severe intraventricular hemorrhage (IVH grade 3–4) or periventricular leukomalacia (PVL); Figure S8: Meta-analysis of the association between male sex of preterm infants and risk of retinopathy of prematurity (ROP, any stage); Figure S9: Meta-analysis of the association between male sex in preterm infants and risk of severe retinopathy of prematurity (ROP grade ≥ 3 or requiring treatment); Figure S10: Meta-analysis of the association between male sex and risk of necrotizing enterocolitis (NEC, any stage) in preterm infants; Figure S11: Meta-analysis of the association between male sex and risk of necrotizing enterocolitis (NEC, stage ≥ II) in preterm infants; Figure S12: Meta-analysis of the association between male sex and risk of mortality before discharge in preterm infants; Figure S13: Funnel plot for publication bias analysis for the studies included in the different meta-analyses.

Author Contributions

Conceptualization, E.V. and E.V.-M.; methodology, E.V. and E.V.-M.; validation, E.v.W.-K., M.J.H..; formal analysis, E.V., E.v.W.-K., M.J.H. and E.V.-M.; investigation, E.V., E.v.W.-K., M.J.H. and E.V.-M.; data curation, E.V., E.v.W.-K., M.J.H. and E.V.-M.; writing—original draft preparation, E.V.; writing—review and editing, E.V., E.v.W.-K., M.J.H. and E.V.-M; visualization, E.V.; supervision, E.V. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

As this systematic review and meta-analysis did not involve animal subjects or personally identifiable information on human subjects, ethics review board approval and patient consent were not required.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data relevant to the study are included in the article or uploaded as supplementary information. Additional data are available upon reasonable request.

Acknowledgments

We thank Zozaya for providing additional data from his study.

Conflicts of Interest

The authors declare no conflict of interest. The views expressed in this paper are those of the authors and do not necessarily reflect the policies of Statistics Netherlands.

References

  1. Raju, T.N.; Buist, A.S.; Blaisdell, C.J.; Moxey-Mims, M.; Saigal, S. Adults born preterm: A review of general health and system-specific outcomes. Acta Paediatr. 2017, 106, 1409–1437. [Google Scholar] [CrossRef] [PubMed]
  2. Ito, M.; Tamura, M.; Namba, F.; Neonatal Research Network of Japan. Role of sex in morbidity and mortality of very premature neonates. Pediatr. Int. 2017, 59, 898–905. [Google Scholar] [CrossRef]
  3. Boghossian, N.S.; Geraci, M.; Edwards, E.M.; Horbar, J.D. Sex differences in mortality and morbidity of infants born at less than 30 weeks’ gestation. Pediatrics 2018, 142, e20182352. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Shim, S.-Y.; Cho, S.J.; Kong, K.A.; Park, E.A. Gestational age-specific sex difference in mortality and morbidities of preterm infants: A nationwide study. Sci. Rep. 2017, 7, 6161. [Google Scholar] [CrossRef] [Green Version]
  5. Mohamed, M.A.; Aly, H. Male gender is associated with intraventricular hemorrhage. Pediatrics 2010, 125, e333–e339. [Google Scholar] [CrossRef] [PubMed]
  6. O’Driscoll, D.N.; McGovern, M.; Greene, C.M.; Molloy, E.J. Gender disparities in preterm neonatal outcomes. Acta Paediatr. 2018, 107, 1494–1499. [Google Scholar] [CrossRef] [Green Version]
  7. McDonald, F.B.; Dempsey, E.M.; O’Halloran, K.D. Caffeine therapy for apnoea of prematurity: Wake up to the fact that sex matters. Exp. Physiol. 2018, 103, 1294–1295. [Google Scholar] [CrossRef]
  8. Saugstad, O.D. Hypoxanthine as an indicator of hypoxia: Its role in health and disease through free radical production. Pediatr. Res. 1988, 23, 143–150. [Google Scholar] [CrossRef] [Green Version]
  9. Perez, M.; Robbins, M.E.; Revhaug, C.; Saugstad, O.D. Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period. Free Rad. Biol. Med. 2019, 142, 61–72. [Google Scholar] [CrossRef]
  10. Vento, M.; Aguar, M.; Escobar, J.; Arduini, A.; Escrig, R.; Brugada, M.; Izquierdo, I.; Asensi, M.A.; Sastre, J.; Saenz, P. Antenatal steroids and antioxidant enzyme activity in preterm infants: Influence of gender and timing. Antioxid. Redox Signal. 2009, 11, 2945–2955. [Google Scholar] [CrossRef]
  11. Lorente-Pozo, S.; Parra-Llorca, A.; Torres, B.; Torres-Cuevas, I.; Nuñez-Ramiro, A.; Cernada, M.; García-Robles, A.; Vento, M. Influence of sex on gestational complications, fetal-to-neonatal transition, and postnatal adaptation. Front. Pediatr. 2018, 6, 63. [Google Scholar] [CrossRef] [PubMed]
  12. Lavoie, J.-C.; Tremblay, A. Sex-specificity of oxidative stress in newborns leading to a personalized antioxidant nutritive strategy. Antioxidants 2018, 7, 49. [Google Scholar] [CrossRef] [Green Version]
  13. Vu, H.D.; Dickinson, C.; Kandasamy, Y. Sex difference in mortality for premature and low birth weight neonates: A systematic review. Am. J. Perinatol. 2018, 35, 707–715. [Google Scholar] [PubMed]
  14. Garfinkle, J.; Yoon, E.W.; Alvaro, R.; Nwaesei, C.; Claveau, M.; Lee, S.K.; Shah, P.S. Trends in sex-specific differences in outcomes in extreme preterms: Progress or natural barriers? Arch. Dis. Child. Fetal Neonatal Ed. 2020, 105, 158–163. [Google Scholar] [CrossRef] [PubMed]
  15. Stroup, D.F.; Berlin, J.A.; Morton, S.C.; Olkin, I.; Williamson, G.D.; Rennie, D.; Moher, D.; Becker, B.J.; Sipe, T.A.; Thacker, S.B. Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA 2000, 283, 2008–2012. [Google Scholar] [CrossRef]
  16. Wells, G.A.; Shea, B.; O’Connell, D.; Peterson, J.; Welch, V.; Losos, M.; Tugwell, P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Oxford. 2000. Available online: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed on 1 July 2020).
  17. Pierro, M.; Villamor-Martinez, E.; van Westering-Kroon, E.; Alvarez-Fuente, M.; Abman, S.H.; Villamor, E. Association of the dysfunctional placentation endotype of prematurity with bronchopulmonary dysplasia: A systematic review, meta-analysis and meta-regression. Thorax 2021. [Google Scholar] [CrossRef]
  18. Villamor-Martinez, E.; Álvarez-Fuente, M.; Ghazi, A.M.; Degraeuwe, P.; Zimmermann, L.J.; Kramer, B.W.; Villamor, E. Association of chorioamnionitis with bronchopulmonary dysplasia among preterm infants: A systematic review, meta-analysis, and metaregression. JAMA Netw. Open 2019, 2, e1914611. [Google Scholar] [CrossRef]
  19. Bertino, E.; Coscia, A.; Boni, L.; Rossi, C.; Martano, C.; Giuliani, F.; Fabris, C.; Spada, E.; Zolin, A.; Milani, S. Weight growth velocity of very low birth weight infants: Role of gender, gestational age and major morbidities. Early Hum. Dev. 2009, 85, 339–347. [Google Scholar] [CrossRef]
  20. Binet, M.-E.; Bujold, E.; Lefebvre, F.; Tremblay, Y.; Piedboeuf, B.; Canadian Neonatal Network. Role of gender in morbidity and mortality of extremely premature neonates. Am. J. Perinatol. 2012, 29, 159–166. [Google Scholar] [CrossRef]
  21. Chen, C.; Tian, T.; Liu, L.; Zhang, J.; Fu, H. Gender-related efficacy of pulmonary surfactant in infants with respiratory distress syndrome: A STROBE compliant study. Medicine 2018, 97, e0425. [Google Scholar] [CrossRef]
  22. Derzbach, L.; Treszl, A.; Balogh, Á.; Vásárhelyi, B.; Tulassay, T. Gender dependent association between perinatal morbidity and estrogen receptor-alpha Pvull polymorphism. J. Perinat. Med. 2005, 33, 461–462. [Google Scholar] [CrossRef] [PubMed]
  23. Deulofeut, R.; Dudell, G.; Sola, A. Treatment-by-gender effect when aiming to avoid hyperoxia in preterm infants in the NICU. Acta Paediatr. 2007, 96, 990–994. [Google Scholar] [CrossRef] [PubMed]
  24. Elsmén, E.; Pupp, I.H.; Hellström-Westas, L. Preterm male infants need more initial respiratory and circulatory support than female infants. Acta Paediatr. 2004, 93, 529–533. [Google Scholar] [CrossRef] [PubMed]
  25. Gagliardi, L.; Rusconi, F.; Reichman, B.; Adams, M.; Modi, N.; Lehtonen, L.; Kusuda, S.; Vento, M.; Darlow, B.A.; Bassler, D. Neonatal outcomes of extremely preterm twins by sex pairing: An international cohort study. Arch. Dis. Child. Fetal Neonatal Ed. 2021, 106, 17–24. [Google Scholar] [CrossRef]
  26. Griesmaier, E.; Santuari, E.; Edlinger, M.; Neubauer, V.; Waltner-Romen, M.; Kiechl-Kohlendorfer, U. Differences in the maturation of amplitude-integrated EEG signals in male and female preterm infants. Neonatology 2014, 105, 175–181. [Google Scholar] [CrossRef]
  27. Harris, C.; Zivanovic, S.; Lunt, A.; Calvert, S.; Bisquera, A.; Marlow, N.; Peacock, J.L.; Greenough, A. Lung function and respiratory outcomes in teenage boys and girls born very prematurely. Pediatr. Pulmonol. 2020, 55, 682–689. [Google Scholar] [CrossRef]
  28. Hintz, S.R.; Kendrick, D.E.; Vohr, B.R.; Poole, W.K.; Higgins, R.D.; NICHD Neonatal Research Network. Gender differences in neurodevelopmental outcomes among extremely preterm, extremely-low-birthweight infants. Acta Paediatr. 2006, 95, 1239–1248. [Google Scholar] [CrossRef] [PubMed]
  29. Huang, H.-M.; Lin, S.-A.; Chang, Y.-C.; Kuo, H.-K. Correlation between periventricular leukomalacia and retinopathy of prematurity. Eur. J. Ophthalmol. 2012, 22, 980–984. [Google Scholar] [CrossRef]
  30. Jennische, M.; Sedin, G. Gender differences in outcome after neonatal intensive care: Speech and language skills are less influenced in boys than in girls at 6.5 years. Acta Paediatr. 2003, 92, 364–378. [Google Scholar] [CrossRef]
  31. Jones, H.P.; Karuri, S.; Cronin, C.M.; Ohlsson, A.; Peliowski, A.; Synnes, A.; Lee, S.K. Actuarial survival of a large Canadian cohort of preterm infants. BMC Pediatr. 2005, 5, 40. [Google Scholar] [CrossRef] [Green Version]
  32. Kent, A.L.; Wright, I.M.; Abdel-Latif, M.E. Mortality and adverse neurologic outcomes are greater in preterm male infants. Pediatrics 2012, 129, 124–131. [Google Scholar] [CrossRef]
  33. Lauterbach, M.D.; Raz, S.; Sander, C.J. Neonatal hypoxic risk in preterm birth infants: The influence of sex and severity of respiratory distress on cognitive recovery. Neuropsychology 2001, 15, 411. [Google Scholar] [CrossRef] [PubMed]
  34. Lavoie, M.E.; Robaey, P.; Stauder, J.E.; Glorieux, J.; Lefebvre, F. Extreme prematurity in healthy 5-year-old children: A re-analysis of sex effects on event-related brain activity. Psychophysiology 1998, 35, 679–689. [Google Scholar] [CrossRef] [PubMed]
  35. Månsson, J.; Fellman, V.; Stjernqvist, K.; EXPRESS Study Group. Extremely preterm birth affects boys more and socio-economic and neonatal variables pose sex-specific risks. Acta Paediatr. 2015, 104, 514–521. [Google Scholar] [CrossRef] [PubMed]
  36. Melamed, N.; Yogev, Y.; Glezerman, M. Effect of fetal sex on pregnancy outcome in twin pregnancies. Obs. Gynecol. 2009, 114, 1085–1092. [Google Scholar] [CrossRef] [PubMed]
  37. Neubauer, V.; Griesmaier, E.; Ralser, E.; Kiechl-Kohlendorfer, U. The effect of sex on outcome of preterm infants—A population-based survey. Acta Paediatr. 2012, 101, 906–911. [Google Scholar] [CrossRef] [Green Version]
  38. Peacock, J.L.; Marston, L.; Marlow, N.; Calvert, S.A.; Greenough, A. Neonatal and infant outcome in boys and girls born very prematurely. Pediatr. Res. 2012, 71, 305–310. [Google Scholar] [CrossRef] [Green Version]
  39. Ramos-Navarro, C.; Sánchez-Luna, M.; Zeballos-Sarrato, S.; Pescador-Chamorro, I. Antenatal corticosteroids and the influence of sex on morbidity and mortality of preterm infants. J. Matern. Fetal Neonatal Med. 2020, 1–8. [Google Scholar] [CrossRef]
  40. Shinwell, E.S.; Reichman, B.; Lerner-Geva, L.; Boyko, V.; Blickstein, I. “Masculinizing” effect on respiratory morbidity in girls from unlike-sex preterm twins: A possible transchorionic paracrine effect. Pediatrics 2007, 120, e447–e453. [Google Scholar] [CrossRef]
  41. Skiöld, B.; Alexandrou, G.; Padilla, N.; Blennow, M.; Vollmer, B.; Ådén, U. Sex differences in outcome and associations with neonatal brain morphology in extremely preterm children. J. Pediatr. 2014, 164, 1012–1018. [Google Scholar] [CrossRef]
  42. Spinillo, A.; Montanari, L.; Gardella, B.; Roccio, M.; Stronati, M.; Fazzi, E. Infant sex, obstetric risk factors, and 2-year neurodevelopmental outcome among preterm infants. Dev. Med. Child Neurol. 2009, 51, 518–525. [Google Scholar] [CrossRef] [PubMed]
  43. Stark, M.J.; Hodyl, N.A.; Wright, I.M.; Clifton, V. The influence of sex and antenatal betamethasone exposure on vasoconstrictors and the preterm microvasculature. J. Matern. Fetal Neonatal Med. 2011, 24, 1215–1220. [Google Scholar] [CrossRef] [PubMed]
  44. Stark, M.J.; Wright, I.M.; Clifton, V.L. Sex-specific alterations in placental 11β-hydroxysteroid dehydrogenase 2 activity and early postnatal clinical course following antenatal betamethasone. Am. J. Physiol. Regul. Integrat. Compar. Physiol. 2009, 297, R510–R514. [Google Scholar] [CrossRef] [PubMed]
  45. Steen, E.E.; Källén, K.; Maršál, K.; Norman, M.; Hellström-Westas, L. Impact of sex on perinatal mortality and morbidity in twins. J. Perinat. Med. 2014, 42, 225–231. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Stevenson, D.K.; Verter, J.; Fanaroff, A.A.; Oh, W.; Ehrenkranz, R.A.; Shankaran, S.; Donovan, E.F.; Wright, L.L.; Lemons, J.A.; Tyson, J.E. Sex differences in outcomes of very low birthweight infants: The newborn male disadvantage. Arch. Dis. Child. Fetal Neonatal Ed. 2000, 83, F182–F185. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Štimac, T.; Šopić-Rahelić, A.-M.; Ivandić, J.; Ekinja, E.; Blickstein, I. Effect of gender on growth-restricted fetuses born preterm. J. Perinat. Med. 2019, 47, 677–679. [Google Scholar] [CrossRef]
  48. Tioseco, J.A.; Aly, H.; Essers, J.; Patel, K.; El-Mohandes, A.A. Male sex and intraventricular hemorrhage. Pediatr. Crit. Care Med. 2006, 7, 40–44. [Google Scholar] [CrossRef]
  49. Tottman, A.C.; Bloomfield, F.H.; Cormack, B.E.; Harding, J.E.; Taylor, J.; Alsweiler, J.M. Sex-specific relationships between early nutrition and neurodevelopment in preterm infants. Pediatr. Res. 2020, 87, 872–878. [Google Scholar] [CrossRef]
  50. Walker, M.; Fitzgerald, B.; Keating, S.; Ray, J.; Windrim, R.; Kingdom, J. Sex-specific basis of severe placental dysfunction leading to extreme preterm delivery. Placenta 2012, 33, 568–571. [Google Scholar] [CrossRef] [PubMed]
  51. Wang, L.-W.; Lin, Y.-C.; Wang, S.-T.; Huang, C.-C.; Taiwan Premature Infant Developmental Collaborative Study Group. Identifying risk factors shared by bronchopulmonary dysplasia, severe retinopathy, and cystic periventricular leukomalacia in very preterm infants for targeted intervention. Neonatology 2018, 114, 17–24. [Google Scholar] [CrossRef] [PubMed]
  52. Zhao, D.; Zou, L.; Lei, X.; Zhang, Y. Gender differences in infant mortality and neonatal morbidity in mixed-gender twins. Sci. Rep. 2017, 7, 8736. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Zisk, J.L.; Genen, L.H.; Kirkby, S.; Webb, D.; Greenspan, J.; Dysart, K. Do premature female infants really do better than their male counterparts? Am. J. Perinatol. 2011, 28, 241–246. [Google Scholar] [CrossRef] [Green Version]
  54. Zozaya, C.; Avila-Alvarez, A.; Arruza, L.; Rodrigo, F.G.-M.; Fernandez-Perez, C.; Castro, A.; Cuesta, M.T.; Vacas, B.; Couce, M.L.; Torres, M.V. The effect of morbidity and sex on postnatal growth of very preterm infants: A multicenter cohort study. Neonatology 2019, 115, 348–354. [Google Scholar] [CrossRef]
  55. Editorial. Putting gender on the agenda. Nature 2010, 465, 665. [Google Scholar] [CrossRef] [PubMed]
  56. Kardys, I.; Vliegenthart, R.; Oudkerk, M.; Hofman, A.; Witteman, J.C. The female advantage in cardiovascular disease: Do vascular beds contribute equally? Am. J. Epidemiol. 2007, 166, 403–412. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Van Oyen, H.; Nusselder, W.; Jagger, C.; Kolip, P.; Cambois, E.; Robine, J.-M. Gender differences in healthy life years within the EU: An exploration of the “health–survival” paradox. Int. J. Public Health 2013, 58, 143–155. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Townsend, E.A.; Miller, V.M.; Prakash, Y. Sex differences and sex steroids in lung health and disease. Endocr. Rev. 2012, 33, 1–47. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Gabory, A.; Roseboom, T.; Moore, T.; Moore, L.; Junien, C. Placental contribution to the origins of sexual dimorphism in health and diseases: Sex chromosomes and epigenetics. Biol. Sex Differ. 2013, 4, 5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Clifton, V. Sex and the human placenta: Mediating differential strategies of fetal growth and survival. Placenta 2010, 31, S33–S39. [Google Scholar] [CrossRef]
  61. Clifton, V.; Stark, M.; Osei-Kumah, A.; Hodyl, N. The feto-placental unit, pregnancy pathology and impact on long term maternal health. Placenta 2012, 33, S37–S41. [Google Scholar] [CrossRef]
  62. Broere-Brown, Z.A.; Adank, M.C.; Benschop, L.; Tielemans, M.; Muka, T.; Gonçalves, R.; Bramer, W.M.; Schoufour, J.D.; Voortman, T.; Steegers, E.A. Fetal sex and maternal pregnancy outcomes: A systematic review and meta-analysis. Biol. Sex Differ. 2020, 11, 26. [Google Scholar] [CrossRef]
  63. Schalekamp-Timmermans, S.; Arends, L.R.; Alsaker, E.; Chappell, L.; Hansson, S.; Harsem, N.K.; Jälmby, M.; Jeyabalan, A.; Laivuori, H. Fetal sex-specific differences in gestational age at delivery in pre-eclampsia: A meta-analysis. Int. J. Epidemiol. 2017, 46, 632–642. [Google Scholar]
  64. James, W.H.; Grech, V. A review of the established and suspected causes of variations in human sex ratio at birth. Early Hum. Dev. 2017, 109, 50–56. [Google Scholar] [CrossRef]
  65. Ingemarsson, I. Gender aspects of preterm birth. BJOG Int. J. Obs. Gynaecol. 2003, 110, 34–38. [Google Scholar] [CrossRef]
  66. Cooperstock, M.; Campbell, J. Excess males in preterm birth: Interactions with gestational age, race, and multiple birth. Obs. Gynecol. 1996, 88, 189–193. [Google Scholar] [CrossRef]
  67. DiPietro, J.A.; Voegtline, K.M. The gestational foundation of sex differences in development and vulnerability. Neuroscience 2017, 342, 4–20. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Martin, J.A.; Hamilton, B.E.; Osterman, M.J.; Driscoll, A.K. Births: Final data for 2019. Natl. Vital Stat. Rep. 2021, 70, 1–51. [Google Scholar]
  69. Peelen, M.J.; Kazemier, B.M.; Ravelli, A.C.; De Groot, C.J.; Van Der Post, J.A.; Mol, B.W.; Hajenius, P.J.; Kok, M. Impact of fetal gender on the risk of preterm birth, a national cohort study. Acta Obs. Gynecol. Scand. 2016, 95, 1034–1041. [Google Scholar] [CrossRef] [Green Version]
  70. Challis, J.; Newnham, J.; Petraglia, F.; Yeganegi, M.; Bocking, A. Fetal sex and preterm birth. Placenta 2013, 34, 95–99. [Google Scholar] [CrossRef] [PubMed]
  71. McElrath, T.F.; Hecht, J.L.; Dammann, O.; Boggess, K.; Onderdonk, A.; Markenson, G.; Harper, M.; Delpapa, E.; Allred, E.N.; Leviton, A. Pregnancy disorders that lead to delivery before the 28th week of gestation: An epidemiologic approach to classification. Am. J. Epidemiol. 2008, 168, 980–989. [Google Scholar] [CrossRef]
  72. Gagliardi, L. Pregnancy complications and neonatal outcomes: Problems and perspectives. Acta Paediatr. 2014, 103, 682–683. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Gagliardi, L.; Rusconi, F.; Da Fre, M.; Mello, G.; Carnielli, V.; Di Lallo, D.; Macagno, F.; Miniaci, S.; Corchia, C.; Cuttini, M. Pregnancy disorders leading to very preterm birth influence neonatal outcomes: Results of the population-based ACTION cohort study. Pediatr. Res. 2013, 73, 794–801. [Google Scholar] [CrossRef] [Green Version]
  74. Gagliardi, L.; Rusconi, F.; Bellu, R.; Zanini, R.; Italian Neonatal Network. Association of maternal hypertension and chorioamnionitis with preterm outcomes. Pediatrics 2014, 134, e154–e161. [Google Scholar] [CrossRef]
  75. Ghidini, A.; Salafia, C.M. Histologic placental lesions in women with recurrent preterm delivery. Acta Obs. Gynecol. Scand. 2005, 84, 547–550. [Google Scholar] [CrossRef] [PubMed]
  76. Cataltepe, D. Historical perspectives: Beyond the first breath: Hyaline membrane disease and constructing the neonatal patient, 1959–1975. NeoReviews 2018, 19, e636–e644. [Google Scholar] [CrossRef]
  77. Farrell, P.M.; Avery, M.E. Hyaline membrane disease. Am. Rev. Respir. Dis. 1975, 111, 657–688. [Google Scholar] [PubMed]
  78. Raghavan, D.; Jain, R. Increasing awareness of sex differences in airway diseases. Respirology 2016, 21, 449–459. [Google Scholar] [CrossRef] [PubMed]
  79. Seaborn, T.; Simard, M.; Provost, P.R.; Piedboeuf, B.; Tremblay, Y. Sex hormone metabolism in lung development and maturation. Trends Endocrinol. Metabol. 2010, 21, 729–738. [Google Scholar] [CrossRef]
  80. Huizing, M.J.; Cavallaro, G.; Moonen, R.M.; González-Luis, G.E.; Mosca, F.; Vento, M.; Villamor, E. Is the C242T polymorphism of the CYBA gene linked with oxidative stress-associated complications of prematurity? Antioxid. Redox Signal. 2017, 27, 1432–1438. [Google Scholar] [CrossRef]
  81. Linsell, L.; Malouf, R.; Morris, J.; Kurinczuk, J.J.; Marlow, N. Prognostic factors for poor cognitive development in children born very preterm or with very low birth weight: A systematic review. JAMA Pediatr. 2015, 169, 1162–1172. [Google Scholar] [CrossRef] [Green Version]
  82. Linsell, L.; Johnson, S.; Wolke, D.; O’Reilly, H.; Morris, J.K.; Kurinczuk, J.J.; Marlow, N. Cognitive trajectories from infancy to early adulthood following birth before 26 weeks of gestation: A prospective, population-based cohort study. Arch. Dis. Child. 2018, 103, 363–370. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Darlow, B.A.; Martin, J.; Horwood, L.J. Metabolic syndrome in very low birth weight young adults and controls: The New Zealand 1986 VLBW Study. J. Pediatr. 2019, 206, 128–133.e5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Antioxidants 10 01490 g001 550
Figure 1. Summary of meta-analyses on the association between obstetric and perinatal characteristics of preterm infants and male sex. CI: confidence interval; K: number of studies; P3: 3rd percentile; P10: 10th percentile; SD: standard deviation.
Figure 1. Summary of meta-analyses on the association between obstetric and perinatal characteristics of preterm infants and male sex. CI: confidence interval; K: number of studies; P3: 3rd percentile; P10: 10th percentile; SD: standard deviation.
Antioxidants 10 01490 g001
Antioxidants 10 01490 g002 550
Figure 2. Summary of meta-analyses on the association between clinical characteristics and outcomes of preterm infants and male sex. BPD: bronchopulmonary dysplasia; CI: confidence interval; IVH: intraventricular hemorrhage; K: number of studies; NEC: necrotizing enterocolitis; PDA: patent ductus arteriosus; PVL: periventricular leukomalacia; ROP: retinopathy of prematurity.
Figure 2. Summary of meta-analyses on the association between clinical characteristics and outcomes of preterm infants and male sex. BPD: bronchopulmonary dysplasia; CI: confidence interval; IVH: intraventricular hemorrhage; K: number of studies; NEC: necrotizing enterocolitis; PDA: patent ductus arteriosus; PVL: periventricular leukomalacia; ROP: retinopathy of prematurity.
Antioxidants 10 01490 g002
Antioxidants 10 01490 g003 550
Figure 3. Meta-regression. (A) Plot showing the correlation between the association of male sex with mortality in preterm infants and the median year of birth of each cohort. A total of 24 studies were included (coefficient, −0.009; standard error, 0.004; p = 0.019; R2-analog, 0.37). (B) Plot showing the correlation between the association of male sex with mortality in preterm infants and mean/median gestational age of each cohort. A total of 18 studies were included (coefficient, 0.051; standard error, 0.014; p < 0.001; R2-analog, 0.75).
Figure 3. Meta-regression. (A) Plot showing the correlation between the association of male sex with mortality in preterm infants and the median year of birth of each cohort. A total of 24 studies were included (coefficient, −0.009; standard error, 0.004; p = 0.019; R2-analog, 0.37). (B) Plot showing the correlation between the association of male sex with mortality in preterm infants and mean/median gestational age of each cohort. A total of 18 studies were included (coefficient, 0.051; standard error, 0.014; p < 0.001; R2-analog, 0.75).
Antioxidants 10 01490 g003
Table
Table 1. Meta-analyses on the association between obstetric and perinatal characteristics of preterm infants and male sex.
Table 1. Meta-analyses on the association between obstetric and perinatal characteristics of preterm infants and male sex.
Meta-AnalysisKRR95% CIpHeterogeneity
Lower LimitUpper LimitI2 (%)p
Chorioamnionitis61.0010.9531.0520.96967.30.009
Hypertensive disorders of pregnancy150.8290.8030.856<0.00122.90.200
Maternal diabetes70.9910.8081.2140.92765.90.007
Smoking during pregnancy30.9870.8001.2180.9013.9<0.001
Prenatal care51.0170.9821.0530.35296.20.353
Premature rupture of membranes61.0060.9471.0680.85262.80.020
Prolonged rupture of membranes50.9680.9141.0260.2750.00.972
Antepartum hemorrhage30.9860.7081.3740.93696.9<0.001
Antenatal corticosteroids210.9920.9821.0030.14344.90.012
Fetal distress30.7840.6780.9070.0010.00.741
Cesarean-section210.9800.9660.9950.00851.50.003
Outborn91.0771.0271.1280.0020.00.682
Apgar 5′ <331.2691.1321.422<0.0010.00.726
Apgar 5′ <731.0100.9461.0770.77285.20.001
Intubation at birth51.0381.0061.0710.01966.40.018
Resuscitation at birth30.9900.6091.6090.96893.2<0.001
Birth weight <P10180.8920.7851.0140.08080.9<0.001
Birth weight <P331.1230.8771.4380.35851.50.127
Continuous variables MD
Gestational age (weeks)24−0.10−0.210.010.07687.0<0.001
Birth weight (g)2447.834.161.5<0.00191.5<0.001
Maternal age (years)100.0−0.50.50.99992.5<0.001
Random effects analysis. Risk ratio (RR) > 1 indicates association of male sex with increased risk of the variable and RR < 1 indicates association of male sex with decreased risk of the variable. K: number of studies, MD: difference of means.
Table
Table 2. Meta-analyses on the association between clinical characteristics and outcomes of preterm infants and male sex.
Table 2. Meta-analyses on the association between clinical characteristics and outcomes of preterm infants and male sex.
Meta-AnalysisKRR95% CIpHeterogeneity
Lower LimitUpper LimitI2 (%)p
Early onset sepsis50.9750.9241.0300.3710.00.459
Late onset sepsis81.0511.0261.077<0.00117.00.296
Undefined onset sepsis81.0830.9621.2180.18620.60.266
Hypotension31.2700.5143.1400.60572.70.026
PDA180.9850.9581.0120.26252.50.004
RDS121.0901.0421.140<0.00196.1<0.001
Surfactant131.0311.0261.036<0.00141.40.059
Mechanical ventilation51.0541.0031.1080.03854.70.066
Pneumothorax91.2401.1041.393<0.00142.20.086
Postnatal steroids61.2341.1691.302<0.00137.60.433
Any BPD71.2001.0911.319<0.00166.00.004
Moderate/severe BPD261.2191.1761.264<0.00171.4<0.001
Any IVH121.1661.1391.193<0.0010.00.680
Severe IVH191.2711.2071.338<0.00140.50.035
PVL131.1100.9711.2690.12877.3<0.001
Severe IVH/PVL31.1581.0231.3100.02080.80.005
Any ROP41.0250.8701.2070.76766.30.031
Severe ROP201.1431.0651.226<0.00179.2<0.001
Any NEC111.1451.0361.2660.00860.10.003
NEC stage ≥ II91.1221.0391.2110.00332.90.155
Mortality201.2271.1631.294<0.00183.7<0.001
Random effects analysis. Risk ratio (RR) > 1 indicates association of male sex with increased risk of the outcome and RR < 1 indicates association of male sex with decreased risk of the outcome. K: number of studies.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

van Westering-Kroon, E.; Huizing, M.J.; Villamor-Martínez, E.; Villamor, E. Male Disadvantage in Oxidative Stress-Associated Complications of Prematurity: A Systematic Review, Meta-Analysis and Meta-Regression. Antioxidants 2021, 10, 1490. https://doi.org/10.3390/antiox10091490

AMA Style

van Westering-Kroon E, Huizing MJ, Villamor-Martínez E, Villamor E. Male Disadvantage in Oxidative Stress-Associated Complications of Prematurity: A Systematic Review, Meta-Analysis and Meta-Regression. Antioxidants. 2021; 10(9):1490. https://doi.org/10.3390/antiox10091490

Chicago/Turabian Style

van Westering-Kroon, Elke, Maurice J Huizing, Eduardo Villamor-Martínez, and Eduardo Villamor. 2021. "Male Disadvantage in Oxidative Stress-Associated Complications of Prematurity: A Systematic Review, Meta-Analysis and Meta-Regression" Antioxidants 10, no. 9: 1490. https://doi.org/10.3390/antiox10091490

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop